Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.

Labinaz M, Mathias J, Pieper K, Granger CB, Lincoff AM, Moliterno DJ, Van de Werf F, Simes J, White HD, Simoons ML, Califf RM, Topol EJ, Armstrong PW, Harrington RA.

Eur Heart J. 2005 Jan;26(2):128-36. Epub 2004 Dec 9.

2.

Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry).

Halkin A, Stone GW, Grines CL, Cox DA, Stuckey TD, Garcia E, Guagliumi G, Mehran R, Rutherford BD, Griffin JJ, Na Y, Tcheng JE, Turco M.

Am J Cardiol. 2005 Dec 15;96(12):1649-55. Epub 2005 Oct 21.

PMID:
16360352
3.

Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.

Lee MS, Sillano D, Latib A, Chieffo A, Zoccai GB, Bhatia R, Sheiban I, Colombo A, Tobis J.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):15-21. doi: 10.1002/ccd.21712.

PMID:
19089930
4.

Prognosis of non-ST-segment elevation acute coronary syndrome in patients with prior percutaneous coronary intervention.

Santos JF, Ferreira J, Aguiar C, Gonçalves P, Raposo L, Almeida M, Seabra-Gomes R.

Rev Port Cardiol. 2005 Jun;24(6):805-16. English, Portuguese.

5.

Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.

Armstrong PW, Fu Y, Westerhout CM, Hudson MP, Mahaffey KW, White HD, Todaro TG, Adams PX, Aylward PE, Granger CB.

J Am Coll Cardiol. 2009 Apr 28;53(17):1503-9. doi: 10.1016/j.jacc.2009.01.046.

6.
7.

Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.

Klein LW, Shaw RE, Krone RJ, Brindis RG, Anderson HV, Block PC, McKay CR, Hewitt K, Weintraub WS; American College of Cardiology National Cardiovascular Data Registry.

Am J Cardiol. 2005 Jul 1;96(1):35-41.

PMID:
15979429
8.

Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.

Timmer JR, Ottervanger JP, de Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes RJ, Granger CB, Zijlstra F; Primary Coronary Angioplasty vs Thrombolysis-2 Trialists Collaborators Group.

Arch Intern Med. 2007 Jul 9;167(13):1353-9.

PMID:
17620527
10.

Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, Lansky AJ, Mehran R, Stone GW.

J Am Coll Cardiol. 2009 Jul 28;54(5):477-86. doi: 10.1016/j.jacc.2009.03.063.

11.

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW.

Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772. Epub 2008 Sep 8.

12.

Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.

Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, Liao ML, Zhang JS, Hu J, Yang ZK, Shen WF.

Chin Med J (Engl). 2008 Mar 20;121(6):485-91.

PMID:
18364130
13.

Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R, Lansky AJ, Grines CL, Stone GW.

Eur Heart J. 2007 Jul;28(14):1709-16. Epub 2007 Jun 7.

14.

Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Zheng AF, Zhang X, Shen WF.

Coron Artery Dis. 2008 Jun;19(4):271-7. doi: 10.1097/MCA.0b013e3282f487e0.

PMID:
18480672
16.
17.
18.

In-hospital outcomes of emergent and elective percutaneous coronary intervention in octogenarians.

Merchant FM, Weiner RB, Rao SR, Lawrence R, Healy JL, Pomerantsev E, Rosenfield K, Jang IK.

Coron Artery Dis. 2009 Mar;20(2):118-23. doi: 10.1097/MCA.0b013e3283292ae1.

PMID:
19293712
19.
20.

The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.

Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, Tcheng JE, Harrington RA, Simoons M, Hu T, Sheikh MA, Kereiakes DJ, Topol EJ.

J Am Coll Cardiol. 2006 Oct 17;48(8):1567-72. Epub 2006 Sep 26.

Items per page

Supplemental Content

Write to the Help Desk